News
-
F-star builds springboard for spectacular growth
F-star Therapeutics, Inc, the Cambridge UK-based biopharma business, has laid the foundations for a game-changing spurt of commercial growth after a... Read More
-
New chair as Darktrace gears up for IPO
Gordon Hurst has taken over as chairman at Cambridge autonomous cyber security AI company Darktrace. He succeeds Robert Webb QC in the role. Hurst... Read More
-
Government pays PragmatIC £1.3m to turn waste into wealth
Cambridge-based flexible electronics pioneer PragmatIC Semiconductor has won a UK government grant for applying its technology to a bleeding edge... Read More
-
Marshall Aerospace and Defence Group accelerates production of life-saving device
Marshall Aerospace and Defence Group has reached an agreement with UK manufacturer Portsmouth Aviation to accelerate production of crucial technology... Read More
-
Acacia Pharma closing in on potentially explosive growth in US
Cambridge business Acacia Pharma is knocking on the door of dominance in the US with its treatments for surgical emergencies, other invasive... Read More
-
Syncona cornerstones $148m Series C in Gyroscope
Eye disease technology from Gyroscope in Stevenage is set to become increasingly influential globally following a $148 million Series C raise.... Read More
-
US influencer partners Congenica in rare disease genomics foray
Sanford Health, a US healthcare delivery system provider, and Cambridge digital health business Congenica have forged a genomics partnership to help... Read More
-
Kao Data joins top table of Cambridge Science Centre STEM initiative
Kao Data, which develops and operates advanced data centres for high performance colocation, has signed a three-year funding agreement with Cambridge... Read More
-
Cambridge biotech out of stealth $80m richer
A new Cambridge and Seattle based biotech company has emerged from stealth with $80 million Series A investment garnered in quickfire time as it aims... Read More
-
Trio of Cambridge women honoured for pioneering innovation
MedTech to level the playing field for ethnic minorities, a storytelling app to help young people manage chronic pain and a tool to combat poisonous... Read More
-
Noahs Ark lands on high ground in chemical shares deal
Law firm Birketts has advised the shareholders of global chemical distributor, Noahs Ark Chemicals, on the sale of their shares to leading... Read More
-
World of entertainment opens up for off-grid households in Kenya
Cambridge CleanTech trailblazer Azuri Technologies has teamed up with MultiChoice Kenya to bring DStv content to off-grid households in the East... Read More
-
Enval feeds Merchant Gourmet’s appetite for change
Merchant Gourmet, the leading healthy pulses and grains brand, has launched a new CleanTech scheme by teaming up with Cambridge-based innovative... Read More
-
Small molecule startup takes bow with £5m investment
A thrusting young life science startup in Cambridge has emerged from stealth in wealth ready to take on the world with a game-changing proposition... Read More
-
New vision for Cambridge Biomedical Campus
Cambridge Biomedical Campus is launching a new vision for the hub and wants local people to put forward their views and help shape its future. The... Read More
-
Clear blue skies as Speechmatics cracks Microsoft Azure
Speechmatics, a Cambridge-based UK leader in any-context speech recognition technology has launched on the Microsoft Azure Marketplace. The company’s... Read More
-
VividQ rearranges its C-Suite to trigger new concepts
Cambridge University spin-out VividQ has juggled its top team to initiate a new wave of display technology innovation. The fresh commercial thrust... Read More
-
San Diego company agrees to acquire Dotmatics
San Diego software provider Insightful Science has agreed to acquire Dotmatics which, from a Bishop’s Stortford base, leverages a cloud-based... Read More
-
Luxury car group invests £30m in new ‘supersite’
H.R. Owen, a luxury automotive dealer group, has begun construction on a new £30 million multi-brand site in Hatfield, Hertfordshire. ... Read More
-
PhoreMost hits its straps after $46m Series B
Cambridge biopharma business PhoreMost has raised $46 million in an oversubscribed Series B round to accelerate key treatments into the clinic.... Read More